Pelvic organ dysfunction is more prevalent and severe in MSA-P compared to parkinson's disease

Autor: Yusuke Awa, Tatsuya Yamamoto, Takashi Ito, Fumio Nomura, Masashi Yano, Tomonori Yamanishi, Mitsuru Yanagisawa, Takamichi Hattori, Chiharu Yamaguchi, Tomoyuki Uchiyama, Satoshi Kuwabara, Ryuji Sakakibara
Rok vydání: 2010
Předmět:
Zdroj: Neurourology and Urodynamics. 30:102-107
ISSN: 0733-2467
DOI: 10.1002/nau.20948
Popis: Aims: It is usually difficult to distinguish between idiopathic Parkinson’s disease (PD) and parkinsonian-type multiple system atrophy (MSA-P) in the early stage. However, it is important to make a careful early-stage diagnosis. Therefore, we determined whether an examination of pelvic organ dysfunction would be helpful to distinguish between PD and MSA-P. Methods: We recruited 61 patients with PD and 54 patients with MSA-P who were examined at our neurology clinic. The mean ages of the patients with PD and MSA-P were 67 and 64 years, respectively. The mean disease duration of both groups was 3.2 years. We administered a questionnaire on pelvic organ dysfunction to the PD and MSA-P groups. The questionnaire had sections focusing on bladder, bowel, and sexual function. Dysfunction, as described in the responses, was evaluated as normal, mild (>once a month), moderate (>once a week), or severe (>once a day). The Mann--Whitney U-test was used for statistical analysis. Results: Compared with the PD group, the prevalence and severity of pelvic dysfunction in the MSA-P group was significantly higher for urinary urgency (MSA-P 76%, PD 58%, P < 0.05), retardation in initiating urination (79%, 48%, P < 0.05), prolongation in urination (79%, 72%, P < 0.05), and constipation (58%, 31%, P < 0.05). The quality-of-life index among pelvic organ dysfunctions indicated that urinary and bowel function was significantly more impaired in the MSA-P group than in the PD group. Conclusions: Urinary urgency, retardation in initiating urination, prolongation in urination, and constipation are more prevalent and severe in MSA-P compared to PD. Neurourol. Urodynam. 30:102–107, 2011. © 2010 Wiley-Liss, Inc.
Databáze: OpenAIRE